AA 147是一种小分子内质网（ER）蛋白稳态调节剂。
Cas No.:393121-74-9
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
AA 147 is a small molecule endoplasmic reticulum (ER) proteostasis regulator. AA 147 can selectively activate the ATF6 arm of the unfolded protein response (UPR) and activate the NRF2 oxidative stress response. AA 147 can be used in research related to neurodegenerative diseases, cardiovascular diseases, and multiple sclerosis[1-4].
In vitro, AA 147 (10μM) pretreated THP1 cells and RAW264.7 mouse macrophages for 16 hours, followed by stimulation with LPS (1μg/mL) and nigericin (10μM) or ATP (5mM) for 3-24 hours. AA 147 significantly inhibited the expression of the pro-inflammatory cytokine IL-1β and reduced the inflammatory response[5]. AA 147 (10μM) treated HT22 cells for 40 hours. AA 147 protected HT22 cells against glutamate-induced oxytosis and erastin-induced ferroptosis[6].
In vivo, AA 147 (2mg/kg) was administered intraperitoneally 1 day before surgery and intravenously 15 minutes after the return of spontaneous circulation, for the treatment of C57BL/6 mice that underwent 9 minutes of cardiac arrest surgery and cardiopulmonary resuscitation. AA 147 significantly improved neurological outcomes and reduced neuronal death[7]. AA 147 (2mg/kg) was administered intraperitoneally 1 hour after stroke, followed by daily injections for 5 days, for the treatment of young (3-4 months old) and aged (18-20 months old) C57BL/6 mice that underwent permanent middle cerebral artery occlusion. AA 147 significantly improved the mice's performance in neurological scores, gait analysis, tape removal test, and Y-maze test, and promoted long-term functional recovery in the mice[8].
References:
[1] Rosarda JD, Baron KR, Nutsch K, et al. Metabolically Activated Proteostasis Regulators Protect against Glutamate Toxicity by Activating NRF2. ACS Chem Biol. 2021 Dec 17;16(12):2852-2863.
[2] Kubra KT, Akhter MS, Saini Y, et al. Activating transcription factor 6 protects against endothelial barrier dysfunction. Cell Signal. 2022 Nov;99:110432.
[3] D'Amico D, Biondi O, Januel C, et al. Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway. Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12816.
[4] Li B, Yang H, Wu H, et al. Hydroquinone-induced endoplasmic reticulum stress affects TK6 cell autophagy and apoptosis via ATF6-mTOR. Environ Toxicol. 2023 Aug;38(8):1874-1890.
[5] Rosarda JD, Stanton CR, Chen EB, et al. Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation. Isr J Chem. 2024 Dec;64(12):e202300125.
[6] Kline GM, Madrazo N, Cole CM, et al. Metabolically activated proteostasis regulators that protect against erastin-induced ferroptosis. RSC Chem Biol. 2024 Jul 17;5(9):866-876.
[7] Yuan Z, Lu L, Lian Y, et al. AA147 ameliorates post-cardiac arrest cerebral ischemia/reperfusion injury through the co-regulation of the ATF6 and Nrf2 signaling pathways. Front Pharmacol. 2022 Nov 23;13:1028002.
[8] Yu X, Dang L, Dhar A, et al. Activation of ATF6 Signaling Confers Long-Term Beneficial Effects in Young and Aged Mice After Permanent Stroke. Transl Stroke Res. 2025 Oct;16(5):1799-1810.
AA 147是一种小分子内质网（ER）蛋白稳态调节剂。AA 147可选择性激活未折叠蛋白反应（UPR）的ATF6臂以及激活NRF2氧化应激反应。AA 147可用于神经退行性疾病、心血管疾病以及多发性硬化等相关研究[1-4]。
在体外，AA 147（10μM）预处理THP1细胞、RAW264.7小鼠巨噬细胞16h，随后以LPS（1μg/mL）和尼日利亚菌素（10μM）或ATP（5mM）刺激3-24h。AA 147显著抑制了促炎因子IL-1β的表达，同时降低炎症反应[5]。AA 147（10μM）处理HT22细胞40小时。AA 147保护HT22细胞免受谷氨酸诱导的氧化应激和erastin诱导的铁死亡[6]。
在体内，AA 147（2mg/kg）在手术前1天腹腔注射和自主循环恢复后15分钟静脉注射，用于处理经历9分钟心脏骤停手术和心肺复苏的C57BL/6小鼠。AA 147显著改善了神经功能结果并减少了神经元死亡[7]。AA 147（2mg/kg）在卒中后1小时腹腔注射，随后每天注射持续5天，用于处理经历永久性大脑中动脉闭塞的年轻（3-4月龄）和老年（18-20月龄）C57BL/6小鼠。AA 147显著改善了小鼠在神经功能评分、步态分析、胶带移除测试和Y迷宫测试的表现，AA 147促进了小鼠的长期功能恢复[8]。
| Cell experiment [1]: | |
Cell lines | HT22 cells (mouse hippocampal neuronal cell line) |
Preparation Method | HT22 cells were pretreated with AA 147 (10μM) for 16 hours prior to challenge with glutamate or erastin. |
Reaction Conditions | 10μM; 16h |
Applications | AA 147 protected HT22 cells against glutamate-induced oxytosis and erastin-induced ferroptosis. AA 147 activated the NRF2 oxidative stress response in neuronal cells. |
| Animal experiment [2]: | |
Animal models | C57BL/6 mice (young 3-4 months old and aged 18-20 months old) |
Preparation Method | AA 147 (2mg/kg) was administered intraperitoneally at 1 hour after permanent middle cerebral artery occlusion (pMCAO), followed by daily injections for 5 days. |
Dosage form | 2mg/kg; i.p.; daily injections for 5 days |
Applications | AA 147 treatment significantly improved long-term functional recovery, including neurologic scores, gait analysis, tape removal test, and Y-maze test performance in both young and aged mice after permanent stroke. |
References: | |
| Cas No. | 393121-74-9 | SDF | |
| Canonical SMILES | CC1=CC(NC(CCC2=CC=CC=C2)=O)=C(C=C1)O | ||
| 分子式 | C16H17NO2 | 分子量 | 255.31 |
| 溶解度 | DMSO : 50 mg/mL (195.84 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.9168 mL | 19.584 mL | 39.1681 mL |
| 5 mM | 783.4 μL | 3.9168 mL | 7.8336 mL |
| 10 mM | 391.7 μL | 1.9584 mL | 3.9168 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet